GRPR and breast cancer: Thus, the combination of two peptidic ligands being able to specifically bind the NPY(Y1)R and the GRPR to one radioligand should enable a considerably higher breast cancer visualization efficiency and sensitivity and thus give less false-negative results compared to the respective monovalent radioligands (Figure 1).